Floatz logo

Epclusa

Bone Diseases, Metabolic

Saskatchewan Health Authority - Regina AreaPhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Bone Diseases, Metabolic cohort.

Asset / SponsorPhaseRating
Biktarvy
Saskatchewan Health Authority - Regina Area
Phase 4BB
Genvoya
Saskatchewan Health Authority - Regina Area
Phase 4BB
VITAMIN D
University of Sao Paulo General Hospital
Phase 4BB
ALENDRONIC ACID
McMaster University
Phase 4BB
Glucose-Dependent Insulinotropic Polypeptide
Esbjerg Hospital - University Hospital of Southern Denmark
N/AD

Same molecule, other indications

Epclusa is also rated in:

chronic hepatitis C virus infectionDormant
BB
Indicative ·
65 / 100
View asset →
diabetes mellitusDormant
BB
Indicative ·
65 / 100
View asset →
opiate dependenceDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →